Sectors
AEMD
Aethlon Medical, Inc.
0.62
3 x 0.59
6 x 0.61
bid
ask
+
0.02
3.06%
03:10 PM
timesize
| Ytd | -77.62% | |
| 1y | -95.41% |
0.59
day range
0.63
0.60
52 week range
27.40
| Open | 0.60 | Prev Close | 0.60 | Low | 0.59 | High | 0.63 | Mkt Cap | 457.99K |
| Vol | 101.29K | Avg Vol | 652.66K | EPS | -10.61 | P/E | -0.06 | Forward P/E | -0.86 |
| Beta | 1.41 | Short Ratio | 0.98 | Inst. Own | 3.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 1.66 | 200-d Avg | 2.90 | 1yr Est | 3.85 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2025-02-12 | 2024-12 | -0.22 | N/A | N/A | N/A |
| 2024-11-13 | 2024-09 | -0.2 | -0.2 | N/A | N/A |
| 2024-08-14 | 2024-06 | -0.44 | -0.34 | 0.1 | 22.73% |
| 2024-06-27 | 2024-03 | -1.18 | -0.91 | 0.27 | 22.88% |
| 2024-02-14 | 2023-12 | -1.23 | -1.37 | -0.14 | -11.38% |
| 2023-11-14 | 2023-09 | -1.35 | -1.22 | 0.13 | 9.63% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-11-15 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-06-24 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-03-04 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2023-10-24 | HC Wainwright & Co. | Upgrade | Buy | Buy |
Profile
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-04-15 | BROENNIMAN EDWARD G | Director | 45.46K | Stock Award(Grant) |
| 2024-04-15 | GIKAKIS NICOLAS | Director | 46.57K | Stock Award(Grant) |
| 2024-04-15 | ROSSETTI ANGELA | Director | 200.54K | Stock Award(Grant) |
| 2024-04-15 | SHAH CHETAN S | Director | 44.53K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | UBS Group AG | 218.25K | 124.30K | 1.56% |
| 2024-09-29 | Geode Capital Management, LLC | 98.39K | 56.04K | 0.70% |
| 2024-09-29 | Vanguard Group Inc | 21.23K | 12.09K | 0.15% |
| 2024-09-29 | Baader Bank Aktiengesellschaft | 17.33K | 9.87K | 0.12% |
| 2024-09-29 | Two Sigma Investments, LP | 15.44K | 8.79K | 0.11% |
| 2024-09-29 | Two Sigma Securities, LLC | 13.74K | 7.82K | 0.10% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity Extended Market Index Fund | 73.86K | 42.06K | 0.53% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 21.22K | 12.09K | 0.15% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 17.41K | 9.92K | 0.12% |
| 2024-10-30 | Fidelity Total Market Index Fund | 2.53K | 1.44K | 0.02% |
Split
| Split | Date |
|---|---|
| 1 : 10 | 2025-10-20 |
| 1 : 8 | 2025-06-09 |
| 1 : 10 | 2023-10-05 |
| 1 : 15 | 2019-10-15 |
| 1 : 50 | 2015-04-14 |